Powder for solution for injection/ infusion.
White to pale yellow crystalline powder.
Meropenem is indicated for the treatment of the following infections in adults and children aged 3 months and older:
Severe pneumonia, including hospital and ventilator-associated pneumonia.
Broncho-pulmonary infections in cystic fibrosis
Complicated urinary tract infections
Complicated intra-abdominal infections
Intra- and post-partum infections
Complicated skin and soft tissue infections
Acute bacterial meningiti
Meropenem Bradex is a broad-spectrum antibiotic belonging to the group carbapenem antibiotics.
The bactericidal effect of meropenem is exerted by inhibiting the bacterial cell wall synthesis of gram-positive and gram-negative bacteria via binding to penicillin-binding proteins (PBP).
As with other beta-lactam antibiotics, the time that meropenem concentrations exceed the minimum inhibitory concentration, MIC, (T> MIC) has been shown to correlate best with effect.
500 mg: 419638
1 g: 057868
Sidan uppdaterades senast 2020-10-20